Presentation TCT 2025 TCT 965: Can Machine Learning Aid the Evaluation of the Risks of Bleeding vs Thrombotic Events in Patients at High Bleeding Risk After PCI? Presenter: Hao-Yu Wang October 28, 2025
Presentation TCT 2025 TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry. Presenter: Claudio Laudani October 28, 2025
Presentation TCT 2025 TCT 1010: Long‑Term Prognostic Significance of High Ischemic versus High Bleeding Risk Phenotypes After Percutaneous Coronary Intervention: HOST-EXAM Extended Study Post Hoc Analysis Presenter: Jin-Eun Song October 27, 2025
Presentation TCT 2025 TCT 999: One- versus three-month DAPT in patients at high or very high bleeding risk undergoing PCI: Results from the XIENCE Short DAPT Program Presenter: Davide Cao October 27, 2025
Presentation TCT 2025 TCT 996: One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI Presenter: Francesca Maria Di Muro October 27, 2025
Presentation TCT 2025 TCT 1824: Going Beyond Metal: The Treatment of a Highly Calcified Long LAD Lesion With Rotatripsy and Sirolimus-Coated Balloon in a Patient With Low Ejection Fraction and High-Bleeding Risk Presenter: Tuomas T. Rissanen October 26, 2025
Presentation TCT 2025 TCT 1822: Treating a Severely Calcified Left Main With Nodular Calcium: Lithotripsy and DCB-Only Strategy in a High Bleeding Risk Case Presenter: Edgar Stroppa Lamas October 26, 2025
Presentation TCT 2025 TCT 143: Safety and Efficacy of Calcium Modification Techniques in Patients With and Without High Bleeding Risk Undergoing PCI Presenter: Joseph Cotton October 26, 2025
Presentation TCT 2025 Antiplatelet Therapy in High Bleeding Risk Patients Following Complex PCI: A HOST-BR Trial Sub-Study Presenter: Hyo-Soo Kim October 25, 2025
Presentation TCT 2025 Aspirin Monotherapy After 1-Month DAPT in High Bleeding Risk Patients Undergoing PCI: The TARGET SAFE Randomized Trial Presenter: Miaohan Qiu October 25, 2025
Presentation NY Valves 2025 My Patient Has Severe Primary MR, Symptomatic AF, and is at High Risk for Stroke and Bleeding: How Do I Time M-TEER and LAAO/Ablation? Presenter: Matthew J. Price June 26, 2025
Presentation TCT 2024 TCT 1248: Drug-Coated Balloon Alone Strategy to Avoid Multiple Stenting in a Patient With High Bleeding Risk Presenter: Marco Luciano Rossi October 30, 2024
Presentation TCT 2024 TCT 959: Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing Transcatheter Aortic Valve Replacement Presenter: Marisa Avvedimento October 30, 2024
Presentation TCT 2024 The Patient with Afib and High Bleeding Risk: Case Selection for Combined Ablation and LAAO? Presenter: Vivek Reddy October 28, 2024
Presentation TCT 2024 TCT 174: High Bleeding Risk and Outcomes in Acute Coronary Syndrome After Percutaneous Coronary Intervention With Versus Without Cangrelor Presenter: Patrick Creechan October 28, 2024
Presentation TCT 2024 Case Presentation: STEMI Patient at High-Bleeding Risk Presenter: Angelo Oliva October 28, 2024
Presentation TCT 2024 TCT 51: Intravascular Imaging-Guided vs Angiography-Guided Complex PCI in Patients With High Bleeding Risk: A Secondary Analysis of the RENOVATE-COMPLEX PCI Trial Presenter: Jinhwan Jo October 28, 2024
Presentation TCT 2024 TCT 1404: Utilization of a Vascular Plug for Left Atrial Appendage Occlusion in High Bleeding Risk Patient and a Challenging Left Atrial Appendage Anatomy Presenter: Amro Alsaid October 28, 2024
Presentation TCT 2024 TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT Presenter: Victor Alfonso Jimenez Diaz October 27, 2024